|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Net Sales | |||
| Cost of goods sold | |||
| Gross profit | |||
| Selling Expenses | |||
| Research and Development | |||
| General and administrative | |||
| Operating loss | |||
| Other income (expense): | |||
| Financing charges | |||
| Interest expense | |||
| Change in fair value of warrant liability | |||
| Change in fair value of derivative liability | |||
| Amortization of debt discount and issuance cost | |||
| Extinguishment of debt liabilities | |||
| Other income | |||
| Other expense | |||
| Total other income (expense), net | |||
| Net loss | |||
| Preferred stock dividends | |||
| Net loss available to common stockholders | |||
| Per-share data | |||
| Basic loss per share | |||
| Diluted loss per share | |||
| Weighted average shares outstanding | |||
| Basic | |||
| Diluted |
Loading...